|
HY-100003-10mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100003-5mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100003-50mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100006A-1mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-10mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-100mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-200mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-25mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-5mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-50mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100007-100mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
|
HY-100007-250mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
|
HY-100013A1-10mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-25mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-5mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-50mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100019-1mg
|
MedChemexpress LLC
|
Rogaratinib [CAS 1443530-05-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100019-10mg
|
MedChemexpress LLC
|
Rogaratinib [CAS 1443530-05-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100019-100mg
|
MedChemexpress LLC
|
Rogaratinib [CAS 1443530-05-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100019-5mg
|
MedChemexpress LLC
|
Rogaratinib [CAS 1443530-05-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100019-50mg
|
MedChemexpress LLC
|
Rogaratinib [CAS 1443530-05-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100022-1mg
|
MedChemexpress LLC
|
Tomivosertib [CAS 1849590-01-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100022-10mg
|
MedChemexpress LLC
|
Tomivosertib [CAS 1849590-01-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100022-100mg
|
MedChemexpress LLC
|
Tomivosertib [CAS 1849590-01-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100022-5mg
|
MedChemexpress LLC
|
Tomivosertib [CAS 1849590-01-7]
|
|
Cancer-Kinase/protease
|
|
